Nexavar, already approved for kidney cancer, shows promise in liver patients
(Newser) -
An impressive clinical trial has produced what could be the first effective drug treatment for liver cancer, the
New York Times reports. Nexavar, which blocks both the blood supply to the tumor and proteins that spur tumor growth, extended the lives of patients in the trial by almost three months,...
More »
